Farabi Pharmaceutical Company (DFARA) financial ratios
Every ratio computed for this symbol, period by period, beside its industry and its own board
- Ticker
- DFARA
- Industry
- Pharmaceuticals
- Market
- Tehran Stock Exchange
Latest periods
| Item | Report to 1404/12/29 | Report to 1403/12/30 | Report to 1402/12/29 | Report to 1401/12/29 |
|---|---|---|---|---|
| P/E TTM | 6.57 | 5.39 | 4.45 | 7.27 |
| P/S TTM | 2.58 | 1.74 | 1.42 | 3.07 |
| P/B | 4.06 | 2.68 | 3.42 | 5.75 |
| Gross margin TTM | 36.7% | 25.9% | 35.4% | 38.5% |
| Net margin TTM | 39.2% | 32.3% | 31.8% | 42.2% |
| ROA TTM | 30.2% | 21.4% | 25.5% | 31.6% |
| ROE TTM | 61.8% | 49.7% | 76.8% | 79.1% |
| Collection period TTM | 282 days | 295 days | 231 days | 248 days |
| Inventory period TTM | 95 days | 107 days | 129 days | 109 days |
| PEG TTM | 0.05 | - | 0.11 | 0.02 |
| PEGY TTM | 0.04 | - | 0.08 | 0.02 |